Literature DB >> 20559900

Human ESC vs. iPSC-pros and cons.

Jane J Pappas1, Phillip C Yang.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 20559900     DOI： 10.1007/s12265-008-9032-2

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN： 1937-5387            Impact factor:   4.132


× No keyword cloud information.
  21 in total

1.  Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution.

Authors:  Nimet Maherali; Rupa Sridharan; Wei Xie; Jochen Utikal; Sarah Eminli; Katrin Arnold; Matthias Stadtfeld; Robin Yachechko; Jason Tchieu; Rudolf Jaenisch; Kathrin Plath; Konrad Hochedlinger
Journal:  Cell Stem Cell       Date:  2007-06-07       Impact factor: 24.633

2.  Generation of human induced pluripotent stem cells from dermal fibroblasts.

Authors:  W E Lowry; L Richter; R Yachechko; A D Pyle; J Tchieu; R Sridharan; A T Clark; K Plath
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-15       Impact factor: 11.205

3.  Reprogramming of human somatic cells to pluripotency with defined factors.

Authors:  In-Hyun Park; Rui Zhao; Jason A West; Akiko Yabuuchi; Hongguang Huo; Tan A Ince; Paul H Lerou; M William Lensch; George Q Daley
Journal:  Nature       Date:  2007-12-23       Impact factor: 49.962

4.  Embryonic stem cell lines derived from human blastocysts.

Authors:  J A Thomson; J Itskovitz-Eldor; S S Shapiro; M A Waknitz; J J Swiergiel; V S Marshall; J M Jones
Journal:  Science       Date:  1998-11-06       Impact factor: 47.728

5.  Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin.

Authors:  Jacob Hanna; Marius Wernig; Styliani Markoulaki; Chiao-Wang Sun; Alexander Meissner; John P Cassady; Caroline Beard; Tobias Brambrink; Li-Chen Wu; Tim M Townes; Rudolf Jaenisch
Journal:  Science       Date:  2007-12-06       Impact factor: 47.728

6.  Generation of germline-competent induced pluripotent stem cells.

Authors:  Keisuke Okita; Tomoko Ichisaka; Shinya Yamanaka
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

7.  In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state.

Authors:  Marius Wernig; Alexander Meissner; Ruth Foreman; Tobias Brambrink; Manching Ku; Konrad Hochedlinger; Bradley E Bernstein; Rudolf Jaenisch
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

8.  Hyaluronic acid-polyethyleneimine conjugate for target specific intracellular delivery of siRNA.

Authors:  Ge Jiang; Kitae Park; Jiseok Kim; Ki Su Kim; Eun Ju Oh; Hyungu Kang; Su-Eun Han; Yu-Kyoung Oh; Tae Gwan Park; Sei Kwang Hahn
Journal:  Biopolymers       Date:  2008-07       Impact factor: 2.505

9.  Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts.

Authors:  Masato Nakagawa; Michiyo Koyanagi; Koji Tanabe; Kazutoshi Takahashi; Tomoko Ichisaka; Takashi Aoi; Keisuke Okita; Yuji Mochiduki; Nanako Takizawa; Shinya Yamanaka
Journal:  Nat Biotechnol       Date:  2007-11-30       Impact factor: 54.908

10.  Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching.

Authors:  Craig J Taylor; Eleanor M Bolton; Susan Pocock; Linda D Sharples; Roger A Pedersen; J Andrew Bradley
Journal:  Lancet       Date:  2005-12-10       Impact factor: 79.321
View more
  10 in total

Review 1.  Integrated Microphysiological Systems: Transferable Organ Models and Recirculating Flow.

Authors:  Kasper Renggli; Nassim Rousset; Christian Lohasz; Oanh T P Nguyen; Andreas Hierlemann
Journal:  Adv Biosyst       Date:  2019-04-01

Review 2.  Emerging roles of the FBW7 tumour suppressor in stem cell differentiation.

Authors:  Zhiwei Wang; Hiroyuki Inuzuka; Hidefumi Fukushima; Lixin Wan; Daming Gao; Shavali Shaik; Fazlul H Sarkar; Wenyi Wei
Journal:  EMBO Rep       Date:  2011-12-23       Impact factor: 8.807

Review 3.  Spinal Muscular Atrophy Modeling and Treatment Advances by Induced Pluripotent Stem Cells Studies.

Authors:  Raffaella Adami; Daniele Bottai
Journal:  Stem Cell Rev Rep       Date:  2019-12       Impact factor: 5.739

4.  Induced Pluripotent Stem Cell-Derived Endothelial Networks Accelerate Vascularization But Not Bone Regeneration.

Authors:  Brianna M Roux; Marcella K Vaicik; Binita Shrestha; Sergio Montelongo; Katerina Stojkova; Feipeng Yang; Teja Guda; Ali Cinar; Eric M Brey
Journal:  Tissue Eng Part A       Date:  2020-10-19       Impact factor: 4.080

Review 5.  Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery.

Authors:  Vimal K Singh; Manisha Kalsan; Neeraj Kumar; Abhishek Saini; Ramesh Chandra
Journal:  Front Cell Dev Biol       Date:  2015-02-02

6.  Profiling parvalbumin interneurons using iPSC: challenges and perspectives for Autism Spectrum Disorder (ASD).

Authors:  Federica Filice; Beat Schwaller; Tanja M Michel; Edna Grünblatt
Journal:  Mol Autism       Date:  2020-01-29       Impact factor: 7.509

Review 7.  Induced Pluripotency: A Powerful Tool for In Vitro Modeling.

Authors:  Romana Zahumenska; Vladimir Nosal; Marek Smolar; Terezia Okajcekova; Henrieta Skovierova; Jan Strnadel; Erika Halasova
Journal:  Int J Mol Sci       Date:  2020-11-24       Impact factor: 5.923

Review 8.  Applications of 3D Bioprinting Technology in Induced Pluripotent Stem Cells-Based Tissue Engineering.

Authors:  Arvind Kumar Shukla; Ge Gao; Byoung Soo Kim
Journal:  Micromachines (Basel)       Date:  2022-01-20       Impact factor: 2.891

Review 9.  Targeting α-Synuclein in Parkinson's Disease by Induced Pluripotent Stem Cell Models.

Authors:  Angeliki Spathopoulou; Frank Edenhofer; Lisa Fellner
Journal:  Front Neurol       Date:  2022-01-25       Impact factor: 4.003

10.  Ten years of progress and promise of induced pluripotent stem cells: historical origins, characteristics, mechanisms, limitations, and potential applications.

Authors:  Adekunle Ebenezer Omole; Adegbenro Omotuyi John Fakoya
Journal:  PeerJ       Date:  2018-05-11       Impact factor: 2.984
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.